The development and validation of the Portuguese risk score for detecting type 2 diabetes and impaired fasting glucose

Primary Care Diabetes

Volumn 7, Issue 1, 2013, Pages 11-18

  Gray, Laura J ^a   Barros, Henrique ^b   Raposo, Luis ^c   Khunti, Kamlesh ^a   Davies, Melanie J ^a   Santos, Ana Cristina ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF PORTO   (Portugal)

^c Portuguese Society of Endocrinology   (Portugal)

Author keywords

Prediction; Prevention; Risk score; Screening; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; BODY MASS; COHORT ANALYSIS; DIET RESTRICTION; EXTERNAL VALIDITY; FEMALE; FOLLOW UP; GROUPS BY AGE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MODEL; NON INSULIN DEPENDENT DIABETES MELLITUS; PORTUGAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HEALTH STATUS INDICATORS; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PORTUGAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; YOUNG ADULT;

EID: 84875244633     PISSN: 17519918     EISSN: 18780210     Source Type: Journal    
DOI: 10.1016/j.pcd.2013.01.003     Document Type: Article

References (38)

1. International Diabetes Federation, IDF Diabetes Atlas, 5th edition, 2011.
2. World Health Organisation, Fact sheet no. 312, Diabetes, 2011.
3. E.B. Levitan Is nondiabetic hyperglycemia a risk factor for cardiovascular disease?: a meta-analysis of prospective studies Archives of Internal Medicine 164 19 2004 2147 2155
4. N. Cortez-Dias Prevalence, management and control of diabetes mellitus and associated risk factors in primary health care in Portugal Revista Portuguesa de Cardiologia 29 4 2010 509 537
5. L. Gardete-Correia First diabetes prevalence study in Portugal: PREVADIAB study Diabetic Medicine 27 2010 879 881
6. C.L. Gillies Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis British Medical Journal 334 299 2007
7. C.L. Gillies Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis British Medical Journal 336 7654 2008 1180 1185
8. National Institute for Health and Clinical Excellence, Public Health Draft Guidence, Preventing type 2 diabetes: risk identification and interventions for individuals at high risk, 2011.
9. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 29 1 2006 543 548
10. F. Guerrero-Romero, and M. Rodriguex-Moran Lowered criterion for normal fasting plasma glucose: impact on the detection of impaired glucose tolerance and metabolic syndrome Archives of Medical Research 37 2006 140 144
11. E. Goyder, et al., National evaluation of DHDS Diabetes Screening Pilot Programme, Final Report, School of Health and Related Research, University of Sheffield, 2008.
12. L.A. Sargeant Who attends a UK diabetes screening programme? Findings from the ADDITION-Cambridge study Diabetic Medicine 27 9 2010 995 1003
13. K. Khunti A comparison of screening strategies for impaired glucose tolerance and type 2 diabetes mellitus in a UK community setting: a cost per case analysis Diabetes Research and Clinical Practice 97 3 2012 505 513
14. G.S. Collins Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting BMC Medicine 9 2011 103
15. B. Buijsse Risk assessment tools for identifying individuals at risk of developing type 2 diabetes Epidemiologic Reviews 33 1 2011 46 62
16. D. Noble Risk models and scores for type 2 diabetes: systematic review British Medical Journal 343 2011 d7163
17. L. Rapsos, A.C. Santos, H. HBarros, The prevalence of the metabolic syndrome in Portugal: the PORMETS study, in preparation.
18. P. Peduzzi A simulation study of the number of events per variable in logistic regression analysis Journal of Clinical Epidemiology 49 12 1996 1373 1379
19. Y. Marchenko, Multiple-imputation analysis using Stata's mi command, Stata Conference, Boston, 2010.
20. L.J. Gray The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting Diabetic Medicine 27 8 2010 887 895
21. S.J. Pocock A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials British Medical Journal 323 2001 75 81
22. R. Vazquez The MUSIC risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure European Heart Journal 2009 10.1093/eurheart/eph032
23. D.W. Hosmer, and S. Lemeshow Applied Logistic Regression 2000 Wiley New York
24. A.C. Santos, and H. Barros Impact of metabolic syndrome definitions on prevalence estimates: a study in a Portuguese community Diabetes & Vascular Disease Research 4 2007 320 327
25. A.C. Santos, M. Severo, and H. Barros Incidence and risk factors for the metabolic syndrome in an urban South European population Preventative Medicine 50 2012 99 105
26. S.J. Griffin Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial Lancet 378 9786 2011 156 167
27. M. van den Donk Screening for type 2 diabetes. Lessons from the ADDITION-Europe study Diabetic Medicine 28 11 2011 1416 1424
28. M. Rahman How much does screening bring forward the diagnosis of type 2 diabetes and reduce complications? Twelve year follow-up of the Ely cohort Diabetologia 55 6 2012 1651 1659
29. P. Chamnan Estimating the potential population impact of stepwise screening strategies for identifying and treating individuals at high risk of Type 2 diabetes: a modelling study Diabetic Medicine 2012 10.1111/j.1464-5491. 2012.03609.x
30. H. Eborall Influences on the uptake of diabetes screening: a qualitative study in primary care British Journal of General Practice 62 596 2012 pe204 pe211
31. U. K. National Screening Committee The Handbook for Vascular Risk Assessment, Risk Reduction and Risk Management 2008 The National Screening Committee London, UK
32. J. Lindstrom, and J. Tuomilehto The diabetes risk score: a practical tool to predict type 2 diabetes risk Diabetes Care 26 3 2003 725 731
33. P. Royston, D.G. Altman, and W. Sauerbrei Dichotomizing continuous predictors in multiple regression: a bad idea Statistics in Medicine 25 1 2006 127 141
34. World Health Organisation Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus 2011 World Health Organisation Geneva
35. S.A. Mostafa The potential impact of using glycated haemoglobin, HbA1c, as the preferred diagnostic tool for Type 2 Diabetes Mellitus Diabetic Medicine 72 2010 762 769
36. L.J. Gray Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting Diabetologia 55 4 2012 959 966
37. L. Molyneaux, M. Constantino, and D. Yue Strong family history predicts a younger age of onset for subjects diagnosed with type 2 diabetes Diabetes, Obesity and Metabolism 6 3 2004 187 194
38. M.A. Babyak What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models Psychosomatic Medicine 66 3 2004 411 421